ReviewTherapeutic innovation & regulatory science2026
Bioequivalence of Generic Semi-solid Topical Dermatological Drug Products: Scientific and Regulatory Perspective from Japan's 2025 Guidelines.
Hiroyuki Yoshida et al.PubMed ↗Publisher ↗
No numbers read from the abstract.